| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| Bioverativ Inc | 2011-08 | Donated | 2018-03 | 31,500 | 1,683 | Cost | 29,817 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| Corporate Stock | 576,166 | 935,042 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| Exchange-Traded Funds | 351,667 | 346,492 | |
| Mutual Funds | 23,700 | 20,540 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| Capital Gain Distributions | 1,670 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Form 990 Penalty & Interest | 19 | |||
| Excise Tax on Investment Income | 1,718 |